Biological
Diphtheria-Tetanus-Pertussis Vaccine clinical trials
- studies test it
- 11
- open now
- 0
- in phase 3
- 8
- first study started
- 2002
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2004 (4)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 2 |
| 2009 | 1 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
- Phase 3
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Often tested with
Tested in the same studies.
Hepatitis B Vaccines (11) · Haemophilus Vaccines (7) · Meningococcal Vaccines (7) · Hiberix (3) · PHiD-CV vaccine (1) · Poliovirus Vaccine, Oral (1) · MVAC Regimen (1) · Yellow Fever Vaccine (1)
Studies
Open first, then newest update. How each study uses Diphtheria-Tetanus-Pertussis Vaccine is read from its arms, and is right about nine times in ten.
Testing it · 11
- Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of AgeCompletedPhase 3GlaxoSmithKlineNCT00814710Written as Tritanrix-HepB/Hib
- Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & InfantsCompletedPhase 2GlaxoSmithKlineNCT01262872Written as Tritanrix™-HepB/Hib
- Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.CompletedPhase 3GlaxoSmithKlineNCT00317135Written as Tritanrix-HepB/Meningitec conjugate vaccine
- Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.CompletedPhase 3GlaxoSmithKlineNCT00317187Written as Tritanrix-HepB/Meningitec conjugate vaccine
- Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in InfantsCompletedPhase 3GlaxoSmithKlineNCT00169442Written as Tritanrix™-HepB/Hiberix™
- Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to InfantsCompletedPhase 3GlaxoSmithKlineNCT00158756Written as Tritanrix™-HepB
- Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at BirthCompletedPhase 3GlaxoSmithKlineNCT00317122Written as DTPw-HBV/Hib-MenAC conjugate vaccine
- Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.CompletedPhase 3GlaxoSmithKlineNCT00317161Written as DTPw-HBV/Hib-MenAC conjugate vaccine
- Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy InfantsCompletedPhase 3GlaxoSmithKlineNCT00290303Written as DTPw-HBV/Hib-MenAC conjugate vaccine
- A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.CompletedPhase 2GlaxoSmithKlineNCT00317174Written as DTPw-HBV/Hib-MenAC conjugate vaccine
- Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to InfantsCompletedPhase 2GlaxoSmithKlineNCT00291967Written as DTPw-HBV/Hib-MenAC conjugate vaccine
Given in every arm · 5 — Diphtheria-Tetanus-Pertussis Vaccine is usual care beside what is tested
- Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850ACompletedPhase 3GlaxoSmithKlineNCT01175083Written as Tritanrix-HepB/Hib
- Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same VaccinesCompletedPhase 3GlaxoSmithKlineNCT00547248Written as Tritanrix-HepB
- Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate VaccineCompletedPhase 3GlaxoSmithKlineNCT00344318Written as Tritanrix-HepB
- Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.CompletedPhase 3GlaxoSmithKlineNCT00829010Written as Tritanrix-HepB/Hib
- A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy InfantsCompletedPhase 3GlaxoSmithKlineNCT02447432Written as DTPw-HBV/Hib
As the comparator · 3 — what is tested is compared with Diphtheria-Tetanus-Pertussis Vaccine
- Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™CompletedPhase 2GlaxoSmithKlineNCT01061541Written as Tritanrix™-HepB
- Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.CompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT00313911Written as Tritanrix-HepB/Hib
- Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™CompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT00534833Written as Tritanrix-HepB/Hib™